pharma-话题@MedSci

#pharma#

608篇内容 | 2515人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908537, encodeId=5d29190853e69, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Myr Pharma的bulevirtide阻断NTCP，在HBV/HDV合并感染患者中展现出强大的抗病毒作用, objectType=article, longId=164358, objectId=b7c5164358c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7c5164358c6, replyNumber=0, likeNumber=71, createdTime=2019-12-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7c5164358c6, moduleTitle=Myr Pharma的bulevirtide阻断NTCP，在HBV/HDV合并感染患者中展现出强大的抗病毒作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7c5164358c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908472, encodeId=c2a619084e2fc, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：研究揭示Hesperetin抑制骨吸收的机制, objectType=article, longId=150754, objectId=d15d150e548c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d15d150e548c, replyNumber=0, likeNumber=67, createdTime=2019-08-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d15d150e548c, moduleTitle=Front Pharmacol：研究揭示Hesperetin抑制骨吸收的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d15d150e548c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908498, encodeId=b149190849827, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：Hsa_circRNA_33287通过miR-214-3p/Runx3促进上颌窦膜干细胞的成骨分化, objectType=article, longId=156811, objectId=1b0c156811e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b0c156811e1, replyNumber=0, likeNumber=117, createdTime=2019-08-14, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b0c156811e1, moduleTitle=Biomed Pharmacother：Hsa_circRNA_33287通过miR-214-3p/Runx3促进上颌窦膜干细胞的成骨分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b0c156811e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908494, encodeId=cb7c1908494e2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Pharmacol Ther：伏立康唑治疗成人侵袭性真菌感染更佳剂量如何确定？, objectType=article, longId=156116, objectId=46171561169a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46171561169a, replyNumber=0, likeNumber=60, createdTime=2019-06-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46171561169a, moduleTitle=Clin Pharmacol Ther：伏立康唑治疗成人侵袭性真菌感染更佳剂量如何确定？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46171561169a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908457, encodeId=e579190845e30, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：高车前素预防老年大鼠由七氟醚诱发的记忆障碍, objectType=article, longId=146495, objectId=749614649581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=749614649581, replyNumber=0, likeNumber=60, createdTime=2019-01-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=749614649581, moduleTitle=Biomed Pharmacother：高车前素预防老年大鼠由七氟醚诱发的记忆障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=749614649581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908470, encodeId=56c219084e09f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子, objectType=article, longId=150549, objectId=dbad1505497d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbad1505497d, replyNumber=0, likeNumber=94, createdTime=2019-02-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbad1505497d, moduleTitle=Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbad1505497d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908454, encodeId=c80d19084547e, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Sun Pharma在美国推出新型Kapspargo Sprinkle（美托洛尔琥珀酸酯）, objectType=article, longId=146126, objectId=08441461269d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08441461269d, replyNumber=0, likeNumber=68, createdTime=2018-08-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08441461269d, moduleTitle=Sun Pharma在美国推出新型Kapspargo Sprinkle（美托洛尔琥珀酸酯）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08441461269d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908458, encodeId=41ae19084583e, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=专访 | Pharma-Vision发起人吴昊伟：服务中国新药研发，这次“我们不一样”, objectType=article, longId=146806, objectId=26ff1468061a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26ff1468061a, replyNumber=0, likeNumber=49, createdTime=2018-09-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26ff1468061a, moduleTitle=专访 | Pharma-Vision发起人吴昊伟：服务中国新药研发，这次“我们不一样”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26ff1468061a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908480, encodeId=00991908480a4, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Redx Pharma宣布新的肺纤维化候选药物RXC006, objectType=article, longId=153632, objectId=d53b15363299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d53b15363299, replyNumber=0, likeNumber=63, createdTime=2019-10-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d53b15363299, moduleTitle=Redx Pharma宣布新的肺纤维化候选药物RXC006, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d53b15363299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908460, encodeId=8aa4190846097, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Curr Clin Pharmacol：改善骨密度和降低成骨不全的骨折风险的干预措施, objectType=article, longId=148046, objectId=171d14804639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=171d14804639, replyNumber=0, likeNumber=56, createdTime=2018-11-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=171d14804639, moduleTitle=Curr Clin Pharmacol：改善骨密度和降低成骨不全的骨折风险的干预措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=171d14804639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908481, encodeId=efda19084812b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Trends Pharmacol Sci：一石二鸟!长寿药竟可治疗阿尔茨海默病！, objectType=article, longId=153969, objectId=3d8215396978, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d8215396978, replyNumber=0, likeNumber=72, createdTime=2018-12-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d8215396978, moduleTitle=Trends Pharmacol Sci：一石二鸟!长寿药竟可治疗阿尔茨海默病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d8215396978)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908491, encodeId=43a119084918a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用, objectType=article, longId=155570, objectId=3d4d1555e01e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4d1555e01e, replyNumber=0, likeNumber=65, createdTime=2019-04-16, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4d1555e01e, moduleTitle=Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4d1555e01e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908533, encodeId=9351190853300, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Brit J Clin Pharmacol:他汀增加糖尿病风险获新证，胖人和HbA1c高者应警惕, objectType=article, longId=163317, objectId=816216331eff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=816216331eff, replyNumber=0, likeNumber=0, createdTime=2020-01-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=816216331eff, moduleTitle=Brit J Clin Pharmacol:他汀增加糖尿病风险获新证，胖人和HbA1c高者应警惕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=816216331eff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908466, encodeId=b955190846651, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果, objectType=article, longId=149962, objectId=b17c149962ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b17c149962ab, replyNumber=0, likeNumber=61, createdTime=2019-03-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b17c149962ab, moduleTitle=Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b17c149962ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908535, encodeId=085a1908535db, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=LEO Pharma和Elektrofi合作改善抗体药物的输送，用于治疗皮肤病, objectType=article, longId=164067, objectId=60c816406e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60c816406e5c, replyNumber=0, likeNumber=86, createdTime=2019-05-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60c816406e5c, moduleTitle=LEO Pharma和Elektrofi合作改善抗体药物的输送，用于治疗皮肤病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60c816406e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908469, encodeId=f61c1908469fe, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：胶原海绵复合骨髓间充质干细胞诱导椎间融合的影响, objectType=article, longId=150548, objectId=f87015054898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f87015054898, replyNumber=0, likeNumber=98, createdTime=2019-01-24, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f87015054898, moduleTitle=Eur Rev Med Pharmacol Sci：胶原海绵复合骨髓间充质干细胞诱导椎间融合的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f87015054898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908474, encodeId=52d219084e49e, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：Ketotifen富马酸盐可减弱与牙龈微环境调节有关的牙龈炎, objectType=article, longId=151025, objectId=49bb151025e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49bb151025e1, replyNumber=0, likeNumber=67, createdTime=2018-10-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49bb151025e1, moduleTitle=Int Immunopharmacol：Ketotifen富马酸盐可减弱与牙龈微环境调节有关的牙龈炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49bb151025e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908487, encodeId=6288190848ed1, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=FDA批准了Intellipharmaceutics的文拉法辛盐酸缓释胶囊, objectType=article, longId=154592, objectId=88751545921e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88751545921e, replyNumber=0, likeNumber=70, createdTime=2019-10-14, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88751545921e, moduleTitle=FDA批准了Intellipharmaceutics的文拉法辛盐酸缓释胶囊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88751545921e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908476, encodeId=410c19084e635, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacoeconomics：PCSK9抑制剂具成本效果吗？, objectType=article, longId=151158, objectId=8d97151158a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d97151158a5, replyNumber=0, likeNumber=71, createdTime=2019-02-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d97151158a5, moduleTitle=Pharmacoeconomics：PCSK9抑制剂具成本效果吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d97151158a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908543, encodeId=fc3c190854390, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究, objectType=article, longId=165386, objectId=e65f1653861d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e65f1653861d, replyNumber=0, likeNumber=68, createdTime=2019-07-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e65f1653861d, moduleTitle=Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e65f1653861d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Myr Pharma的bulevirtide阻断NTCP，在HBV/HDV合并感染患者中展现出强大的抗病毒作用

2019-12-01

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：研究揭示Hesperetin抑制骨吸收的机制

2019-08-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：Hsa_circRNA_33287通过miR-214-3p/Runx3促进上颌窦膜干细胞的成骨分化

2019-08-14

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Pharmacol Ther：伏立康唑治疗成人侵袭性真菌感染更佳剂量如何确定？

2019-06-03

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：高车前素预防老年大鼠由七氟醚诱发的记忆障碍

2019-01-31

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子

2019-02-04

chentianping (审核中...)

前往app查看评论内容

#pharma#

Sun Pharma在美国推出新型Kapspargo Sprinkle（美托洛尔琥珀酸酯）

2018-08-20

chentianping (审核中...)

前往app查看评论内容

#pharma#

专访 | Pharma-Vision发起人吴昊伟：服务中国新药研发，这次“我们不一样”

2018-09-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Redx Pharma宣布新的肺纤维化候选药物RXC006

2019-10-31

chentianping (审核中...)

前往app查看评论内容

#pharma#

Curr Clin Pharmacol：改善骨密度和降低成骨不全的骨折风险的干预措施

2018-11-25

chentianping (审核中...)

前往app查看评论内容

#pharma#

Trends Pharmacol Sci：一石二鸟!长寿药竟可治疗阿尔茨海默病！

2018-12-19

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用

2019-04-16

chentianping (审核中...)

前往app查看评论内容

#pharma#

Brit J Clin Pharmacol:他汀增加糖尿病风险获新证，胖人和HbA1c高者应警惕

2020-01-19

chentianping (审核中...)

前往app查看评论内容

#pharma#

Ra Pharma宣布Zilucoplan在肾功能不全患者中的药代动力学结果

2019-03-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

LEO Pharma和Elektrofi合作改善抗体药物的输送，用于治疗皮肤病

2019-05-17

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：胶原海绵复合骨髓间充质干细胞诱导椎间融合的影响

2019-01-24

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：Ketotifen富马酸盐可减弱与牙龈微环境调节有关的牙龈炎

2018-10-28

chentianping (审核中...)

前往app查看评论内容

#pharma#

FDA批准了Intellipharmaceutics的文拉法辛盐酸缓释胶囊

2019-10-14

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacoeconomics：PCSK9抑制剂具成本效果吗？

2019-02-18

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：宝霍赛德I抗骨质疏松活性的初步研究

2019-07-28

科室
- - 订阅+
  - 更多科室
工具
服务